Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-24 @ 6:44 PM
NCT ID:
NCT05119257
Eligibility Criteria:
Inclusion Criteria:
* Documented diagnosis of advanced malignant disease
* Advanced malignant disease without any available standard of care treatment option
* Live expectancy \> 3 month
* Ability to understand and voluntarily sign an informed consent form.
* Ability to adhere to the visit schedule and other protocol requirements
* Eastern Cooperative Oncology Group (ECOG) performance status score of ≤ 2.
Exclusion Criteria:
* Pregnant or lactating females.
* Treatment regimens inducing severe T cell deficiencies
* Treatment-related side effect from prior cancer treatment \> CTC grade 2 (CTCAE V5.0)
* Participation in any clinical study or having taken any investigational therapy, which would interfere with the studys primary and secondary end points within 2 weeks prior to Ab treatment.
Sex:
ALL
Study:
NCT05119257
Study Brief:
Protocol Section:
NCT05119257